Opportunity Information: Apply for PAR 12 045
Apply for PAR 12 045
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIAMS Small Grant Program For New Investigators (R03)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.846 Arthritis, Musculoskeletal and Skin Diseases Research.
- This funding opportunity was created on Aug 27, 2014 and posted on Nov 30, 2011.
- Applicants must submit their applications by Mar 20, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $25,000.00 in funding.
- Eligible applicants include: Private institutions of higher education Small businesses For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Special district governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled Additional Information on Eligibility for clarification) Independent school districts Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments State governments Public housing authorities/Indian housing authorities.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NIAMS Small Grant Program for New Investigators (R03), Funding Opportunity Number PAR-12-045, is a National Institutes of Health (NIH) discretionary grant opportunity run by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). It is designed to help promising new investigators get established in NIAMS-relevant research areas by providing small, targeted funding for early-stage or pilot studies. The central purpose is to generate the preliminary data, proof-of-concept findings, or feasibility results that position an investigator to compete for a larger, subsequent individual research project grant, especially an R01. In practical terms, this program is meant to support focused, limited-scope projects that can be completed with modest resources but have a clear path toward a more comprehensive research program.
The scientific focus is on research related to arthritis and musculoskeletal and skin diseases and injuries, aligning with NIAMS mission areas. The mechanism is the NIH R03 small grant, which typically supports concise projects rather than full-scale multi-aim research programs. A key restriction is that clinical trials of any phase are not supported under this funding announcement, meaning applicants should not propose interventional studies that meet the NIH definition of a clinical trial. Projects should instead emphasize non-clinical-trial research approaches such as basic, translational (non-trial), mechanistic, methodological, epidemiologic (non-trial), or other preclinical and observational work, as appropriate to NIAMS priorities and NIH rules.
Financially, the opportunity listed an estimated total funding amount of $1,500,000 and an award ceiling of $25,000, with no cost sharing or matching requirement. This relatively small budget cap reinforces the pilot nature of the program: applicants are expected to propose a tightly scoped study with a well-defined endpoint and a strong justification for how the results will enable a future, larger application. Because the goal is progression to an R01 or similar award, competitive applications typically emphasize a clear next step, a compelling rationale for why these pilot data are essential, and a plan that can realistically be executed within the constraints of a small grant.
Eligibility is broad across many U.S.-based organization types. Eligible applicants include public and state-controlled and private institutions of higher education, nonprofits (including 501(c)(3) and certain non-501(c)(3) entities), small businesses, and other for-profit organizations, as well as a range of government entities (state, county, city or township, special district governments, and independent school districts). The announcement also explicitly includes various mission-driven and community-centered organizations and institution types such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, faith-based or community-based organizations, regional organizations, U.S. territories or possessions, and tribal governments (including federally recognized and other tribal organizations, as specified). At the same time, the FOA clearly excludes non-domestic (non-U.S.) entities: foreign institutions are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components (as defined by the NIH Grants Policy Statement) are not allowed.
From a timing and administrative standpoint, the opportunity was originally posted on November 30, 2011, with key dates showing an original closing date of November 20, 2014, a current closing date of March 20, 2015, and an archive date of April 19, 2015. The CFDA number associated with this program is 93.846 (Arthritis, Musculoskeletal and Skin Diseases Research). The full announcement was made available through NIH’s grants guide, and NIH’s Office of Extramural Research (OER) webmaster contact information was provided for access or linking issues.
FAQs: NIAMS Small Grant Program for New Investigators (R03) - PAR-12-045
What is the NIAMS Small Grant Program for New Investigators (R03)?
The NIAMS Small Grant Program for New Investigators (R03) is an NIH discretionary grant opportunity administered by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). It provides small, targeted funding to help promising new investigators get established in NIAMS-relevant research areas through early-stage or pilot studies.
What is the Funding Opportunity Number for this program?
The Funding Opportunity Number (FOA) is PAR-12-045.
What is the main purpose of this R03 opportunity?
The central purpose is to support limited-scope studies that generate preliminary data, proof-of-concept findings, or feasibility results. These outcomes are intended to position an investigator to compete for a larger subsequent individual research project grant, especially an R01.
What types of projects are a good fit for this program?
This program is meant for focused, modest-resource projects with clear endpoints that can be completed as early-stage or pilot work. The expectation is that the project will create a direct path toward a more comprehensive research program and a future larger application.
What scientific areas does NIAMS expect applicants to address?
The scientific focus is research related to arthritis and musculoskeletal and skin diseases and injuries, consistent with NIAMS mission areas.
What grant mechanism is used?
The mechanism is the NIH R03 small grant, which is typically intended for concise projects rather than full-scale, multi-aim research programs.
Are clinical trials allowed under this funding opportunity?
No. Clinical trials of any phase are not supported under this funding announcement. Applicants should not propose interventional studies that meet the NIH definition of a clinical trial.
If clinical trials are not allowed, what kinds of approaches can be proposed?
The FOA indicates projects should emphasize non-clinical-trial research approaches such as basic research, translational research (non-trial), mechanistic studies, methodological work, epidemiologic research (non-trial), or other preclinical and observational work, as appropriate to NIAMS priorities and NIH rules.
How much total funding was estimated for this opportunity?
The estimated total funding amount listed for the opportunity is $1,500,000.
What is the award ceiling for an individual grant under this FOA?
The award ceiling is $25,000.
Is cost sharing or matching required?
No. The FOA states there is no cost sharing or matching requirement.
How should applicants think about the small budget cap?
The relatively small award ceiling reinforces the pilot nature of the program. Proposed work is expected to be tightly scoped, feasible with modest resources, and justified in terms of how the results will enable a future, larger application (often an R01).
What makes an application competitive, based on the stated goals of the program?
Based on the program purpose described, competitive applications typically emphasize a compelling rationale for the pilot work, explain why the preliminary data are essential, define a well-scoped plan with a realistic endpoint, and clearly describe the next step toward an R01 or similar award.
What organizations are eligible to apply?
Eligibility is broad across many U.S.-based organization types, including public and state-controlled and private institutions of higher education, nonprofits (including 501(c)(3) and certain non-501(c)(3) entities), small businesses, other for-profit organizations, and a range of government entities (state, county, city or township, special district governments, and independent school districts).
Are mission-driven and community-centered organizations included as eligible applicants?
Yes. The announcement explicitly includes various institution and organization types such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, faith-based or community-based organizations, regional organizations, U.S. territories or possessions, and tribal governments (including federally recognized and other tribal organizations, as specified).
Are foreign (non-U.S.) entities eligible to apply?
No. The FOA excludes non-domestic (non-U.S.) entities. Foreign institutions are not eligible to apply.
Can a U.S. organization apply if the project includes a non-domestic component?
No. The FOA states that non-domestic components of U.S. organizations are not eligible, and foreign components (as defined by the NIH Grants Policy Statement) are not allowed.
When was this opportunity originally posted?
The opportunity was originally posted on November 30, 2011.
What were the closing and archive dates listed?
Key dates listed include an original closing date of November 20, 2014, a current closing date of March 20, 2015, and an archive date of April 19, 2015.
What CFDA number is associated with this program?
The CFDA number associated with this program is 93.846 (Arthritis, Musculoskeletal and Skin Diseases Research).
Where was the full announcement made available?
The full announcement was made available through NIH's grants guide.
Who was listed as a contact for access or linking issues?
NIH's Office of Extramural Research (OER) webmaster contact information was provided for access or linking issues.
What is NIAMS within NIH in this context?
Within NIH, NIAMS is the National Institute of Arthritis and Musculoskeletal and Skin Diseases, and it is the institute running this discretionary grant opportunity.
What is the intended outcome after completing an R03 project under this FOA?
The intended outcome is to produce preliminary or feasibility results that strengthen the investigator's ability to pursue a larger, subsequent grant, particularly an R01, by demonstrating proof of concept and readiness for a broader research program.
Browse more opportunities from the same category: Health
Next opportunity: Identifying Heart, Lung, and Blood Disease Causing Variants (R01)
Previous opportunity: NIST Center for Neutron Research (NCNR) Comprehensive Grant Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 12 045
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 12 045) also looked into and applied for these:
| Funding Opportunity |
|---|
| Identifying Heart, Lung, and Blood Disease Causing Variants (R01) Apply for PAR 12 043 Funding Number: PAR 12 043 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of Courses or Workshops in Metabolomics (R25) Apply for RFA RM 11 018 Funding Number: RFA RM 11 018 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Critical Congenital Heart Disease Newborn Screening Demonstration Program Apply for HRSA 12 127 Funding Number: HRSA 12 127 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Mentored Research Scientist Development Award in Metabolomics (K01) Apply for RFA RM 11 017 Funding Number: RFA RM 11 017 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| AHRQ Patient Centered Outcomes Research Institutional Award (K12) Apply for RFA HS 12 001 Funding Number: RFA HS 12 001 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $600,000 |
| New Methods for Understanding the Functional Role of Human DNA Sequence Variants in Complex Phenotypes (R01) Apply for RFA GM 13 002 Funding Number: RFA GM 13 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Regional Comprehensive Metabolomics Resource Cores (RCMRC) (U24) Apply for RFA RM 11 016 Funding Number: RFA RM 11 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Metabolomics Data Repository and Coordinating Center (DRCC) (U01) Apply for RFA RM 11 020 Funding Number: RFA RM 11 020 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Community Empowerment of People Against Tuberculosis (CEPAT) Apply for RFA 497 11 000005 Funding Number: RFA 497 11 000005 Agency: Indonesia USAID Jakarta Category: Health Funding Amount: $4,000,000 |
| Stroke Prevention/Intervention Research Program (SPIRP) (U54) Apply for RFA NS 12 007 Funding Number: RFA NS 12 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Radiological/Nuclear Medical Countermeasure Product Development Program (SBIRR43/R44) Apply for PA 12 044 Funding Number: PA 12 044 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Ancillary Studies in Clinical Trials (R01) Apply for RFA HL 13 003 Funding Number: RFA HL 13 003 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Systems Strengthening for Better HIV/TB Patient Outcomes Apply for RFA 674 12 000002 Funding Number: RFA 674 12 000002 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $150,000,000 |
| Advanced Neural Prosthetics Research and Development (SBIR U44) Apply for PAR 12 054 Funding Number: PAR 12 054 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| National Public Health Practice and Resource Centers on Health Promotion for People with Disabilities Apply for CDC RFA DD12 1205 Funding Number: CDC RFA DD12 1205 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| National Training Mechanism (NTM) Apply for RFA 615 12 000001 Funding Number: RFA 615 12 000001 Agency: Kenya USAID Nairobi Category: Health Funding Amount: $40,000,000 |
| APHIAplus Northern Arid Lands (APHIAplus NAL) Apply for RFA 615 12 000002 Funding Number: RFA 615 12 000002 Agency: East Africa USAID Kenya Category: Health Funding Amount: $50,000,000 |
| National Center for HIV/AIDS, Viral Hepatitis, Sexually Transmitted Diseases and Tuberculosis Prevention, Public Health Conference Support Apply for CDC RFA PS12 1204 Funding Number: CDC RFA PS12 1204 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Development and Evaluation of a Clinic Based Screening and Brief Intervention (SBI) for Changing Behaviors Related to Cytomegalovirus (CMV) Transmission in Pregnant Women Apply for RFA DD 12 005 Funding Number: RFA DD 12 005 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Postbaccalaureate Research Education Program (PREP) (R25) Apply for PAR 12 056 Funding Number: PAR 12 056 Agency: National Institutes of Health Category: Health Funding Amount: $375,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 12 045", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.